Skip to main navigation Skip to search Skip to main content

Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen

  • Daniele Armenia
  • , Domenico Di Carlo
  • , Alessandro Cozzi-Lepri
  • , Andrea CALCAGNO
  • , Vanni Borghi
  • , Caterina Gori
  • , Ada Bertoli
  • , William Gennari
  • , Rita Bellagamba
  • , Antonella Castagna
  • , Alessandra Latini
  • , Carmela Pinnetti
  • , Stefania Cicalini
  • , Annalisa Saracino
  • , Giuseppe Lapadula
  • , Stefano Rusconi
  • , Francesco Castelli
  • , Simona Di Giambenedetto
  • , Massimo Andreoni
  • , Giovanni Di Perri
  • Andrea Antinori, Cristina Mussini, Francesca Ceccherini-Silberstein, Antonella D'Arminio Monforte, Carlo F Perno, Maria M Santoro

Research output: Contribution to journalArticlepeer-review

Abstract

Pre-cART (combined antiretroviral therapy) plasma viral load >500,000 copies/mL has been associated with a lower probability of achieving virological suppression, while few data about its role on maintenance of virological suppression are available. In this study we aimed to clarify whether high levels of pre-cART viremia are associated with virological rebound (VR) after virological suppression.
Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalAntiviral Therapy
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen'. Together they form a unique fingerprint.

Cite this